Johnson & Johnson COVID vaccine allotment will be ‘relatively low’ until Baltimore plant that ruined doses gets FDA approval
Maryland health officials expect to see a drastic reduction in the state’s allocation of Johnson & Johnson’s COVID-19 vaccine next week — a shortfall that will lead to a 33% drop overall in the availability of first- or single-dose vaccines compared to this week, officials said.